Skip to content
Neuropeptides

Cerebrolysin

Cerebrolysin is a porcine brain-derived peptide preparation described as neurotrophic-like. Approved business buyers can apply for wholesale access.

US Peptide Distributors supplies Cerebrolysin at wholesale to approved business buyers. Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Pricing is quoted by supply option: USA stock, USA-synthesized or overseas-sourced, and USA stock offers same-day shipping with no minimum order.

Updated

Synonyms
Porcine brain-derived peptide preparation, CBL

Approved buyers see pricing

Wholesale pricing is available to approved business buyers after they log in.

Supply and testing

  • Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
  • Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
  • Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
  • No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
  • COA in your company nameCan be added to an order and is provided with it.

Distributor programShipping times

Request a quote for Cerebrolysin

A mixture, not a molecule

Cerebrolysin does not have a single sequence, formula or molecular weight. It is a preparation derived from pig brain, and the literature describes it as a mix of brain-derived peptides with activity resembling that of neurotrophic factors. Any specification therefore has to describe a population of peptides, and a certificate that reports one mass peak would be a poor fit for the material.

That makes it different from every single-sequence compound in this catalogue. Quality discussions turn on how the profile of the whole mixture is characterised and how consistent it is from lot to lot, rather than on the identity of one analyte. For that reason the cited sources below speak of the preparation, not of a defined active peptide.

Laboratory findings

  • Rat motor-cortex lesion model. In female Sprague-Dawley rats given a kainic acid lesion of the motor cortex, a group in Guadalajara administered Cerebrolysin ten days later. Scores on the BBB and Bederson motor scales were better, motoneurons in the ventral spinal cord showed more dendritic intersections and greater spine density, and the growth-associated protein GAP43 was higher. The authors suggest that plastic change through GAP43 and other proteins may be involved.
  • Neuro-2A cell culture. A study from Chennai exposed Neuro-2A cells to tert-butyl hydroperoxide as an oxidative stress model. Cell-viability readouts differed modestly but significantly from controls with Cerebrolysin and with citicoline. Of the genes examined, Neuregulin 1 expression rose with Cerebrolysin, and both agents raised BDNF expression. The authors themselves call the result a preliminary clue.

Clinical research

Cerebrolysin has also been the subject of human clinical trials, and a 2019 Cochrane systematic review of randomised trials is listed in the references. We list the review so readers can examine the trial evidence directly and weigh its quality for themselves; this page does not summarise outcomes.

Supply notes

Because the material is a complex mixture, ask suppliers what profile data accompany each lot and how lot-to-lot comparability is shown. Our guide on batch COAs sets out typical contents. Supply is for approved business buyers, for laboratory research use only.

References

  1. Martínez-Torres NI, et al. Cerebrolysin Induces Motor Recovery Along with Plastic Changes in Motoneurons and an Increase in GAP43 Protein in the Ventral Spinal Cord Following a Kainic Acid Excitotoxic Lesion in the Rat Motor Cortex. Neurochem Res. 2024.
  2. P A, et al. Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of Brain-Derived Neurotrophic Factor (BDNF) Expression in the Affected Neural Cells: A Preliminary Clue Obtained Through an In Vitro Study. Cureus. 2024.
  3. Cui S, et al. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2019.

Questions

Where can I buy Cerebrolysin in bulk?

US Peptide Distributors supplies Cerebrolysin to approved business buyers. Apply for a buyer account to see wholesale pricing by supply option (USA stock, USA-synthesized or overseas-sourced). There is no minimum order on USA stock, and larger volumes are quoted on request.

Is Cerebrolysin sold for use in humans?

No. US Peptide Distributors sells Cerebrolysin to approved business buyers for laboratory research use only, not for use in humans.

Is each lot of Cerebrolysin third-party tested?

Yes. Every lot US Peptide Distributors supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.